Pharming Group, DSM to participate in Dutch BioMedical Materials consortium

By Lisa Kerner

Erie, Pa., May 16 - Netherlands-based Pharming Group NV and DMS said Tuesday they are two of several organizations participating in the BioMedical Materials consortium (BMM) designed to provide leadership to the Netherlands in biomedical materials and facilitate novel product development.

Other industrial companies, small and medium-sized companies, knowledge institutes and public organizations participating in the consortium are Koninklijke DSM NV, Fortimedix, Fuji-Life Sciences, Innocore, Medtronic, Organon, Philips Research, Pharmacell, Polyganics, De Nierstichting, Radboud Universiteit Nijmegen, Rijksuniversiteit Groningen, Technische Universiteit Eindhoven, TNO, Universiteit Maastricht, Universiteit Twente, and Universiteit Utrecht.

The BMM has a provisional budget of €120 million over five years, with plans to seek additional public funding from the Dutch government, according to a news release.

Research activities among consortium participants could begin in the third quarter.

Pharming Group develops potential treatments for genetic disorders, specialty products for surgical indications, intermediates for various applications and food products.

DSM's products are used in a wide range of end markets and applications such as human and animal nutrition and health, cosmetics, pharmaceuticals, automotive and transport, coatings, housing and electronics.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.